# US 2026/0240961 A1 · Nutritional compositions comprising a recombinant polypeptide which has a nutritionally complete amino acid profile

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0240961 A1
- Document ID: US20260240961A1
- Status: Published application
- Kind: A1
- Application number: 19/159,316
- Filed: 2024-02-29
- Published: 2026-08-20
- Earliest claimed: 2023-03-02
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Jesper VIND; Morten GJERMANSEN; Birgitte ANDERSEN
- Web page: https://patentgrep.com/patent/US20260240961A1

## CPC

- A23L 33/18: Peptides; Protein hydrolysates
- A61K 38/47: acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A23L 33/17: Amino acids, peptides or proteins
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C12N 15/80: for fungi
- C12Y 302/01025: Beta-mannosidase (3.2.1.25), i.e. mannanase
- A61K 38/16: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The invention provides a nutritional composition comprising a recombinant polypeptide that has a nutritionally complete amino acid profile suitable for daily human consumption for general nutrition and specialized nutrition. The invention further provides a recombinant polypeptide and variants and truncates thereof which are suitable to provide a nutritionally complete amino acid profile when provided in a nutritional composition. The invention also provides polynucleo-tides encoding the recombinant polypeptides, nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of producing said recombinant polypeptides.

## Claims

### Claim 1

A nutritional composition suitable as a complete protein source for Phenylketonuria (PKU) patients, wherein the composition comprises a recombinant polypeptide which has a nutritionally complete amino acid profile for PKU patients.

### Claim 2 (depends on 1)

The nutritional composition of claim 1, wherein the composition does not comprise added free amino acids.

### Claim 3 (depends on 1)

The nutritional composition of claim 1, wherein the recombinant polypeptide comprises no phenylalanine residues.

### Claim 4 (depends on 1)

The nutritional composition of claim 1, wherein the Amino Acid Score (AAS) of the polypeptide is equal to or greater than 0.94, aside from phenylalanine.

### Claim 5 (depends on 1)

The nutritional composition of claim 1, wherein the recombinant polypeptide comprises:
a) at least 50 mg threonine per gram polypeptide
b) at least 9 mg tryptophan per gram polypeptide
c) at least 55 mg tyrosine per gram polypeptide; and
d) at least 66 mg leucine per gram polypeptide.

### Claim 6 (depends on 1)

The nutritional composition of claim 1, wherein the recombinant polypeptide comprises an amino acid sequence which has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% sequence identity, or at least 100% sequence identity, to the amino acid sequence of any one of SEQ ID NOs: 2 to 48.

### Claim 7 (depends on 1)

The nutritional composition of claim 1, further comprising vitamins and minerals in amounts sufficient to meet daily requirements.

### Claim 8 (depends on 1)

The nutritional composition of claim 1, further comprising a carbohydrate source and/or a fat source.

### Claim 9 (depends on 1)

The nutritional composition of claim 1, wherein the composition is a tablet, dispersible powder, granule, capsule, liquid, suspension, or syrup.

### Claim 10

A nutritional composition suitable as a complete protein source, wherein the composition comprises a recombinant polypeptide which has an AAS greater than or equal to 0.94 and the recombinant polypeptide comprises at least 132 mg leucine per gram polypeptide.

### Claim 11 (depends on 10)

The nutritional composition of claim 10, wherein the recombinant polypeptide further comprises at least 230 mg branched chain amino acids per gram polypeptide.

### Claim 12 (depends on 10)

The nutritional composition of claim 10, further comprising vitamins and minerals in amounts sufficient to meet daily requirements.

### Claim 13 (depends on 10)

The nutritional composition of claim 10, further comprising a carbohydrate source and/or a fat source.

### Claim 14 (depends on 10)

The nutritional composition of claim 10, wherein the composition is a tablet, dispersible powder, granule, capsule, liquid, suspension, or syrup.

### Claim 15

A polypeptide comprising the amino acid sequence of SEQ ID NOs: 2 to 48.

### Claim 16 (depends on 15)

An isolated polynucleotide encoding the polypeptide of claim 15.

### Claim 17 (depends on 16)

A nucleic acid construct or expression vector comprising the polynucleotide of claim 16.

### Claim 18 (depends on 16)

A recombinant host cell transformed with the polynucleotide of claim 16.

### Claim 19 (depends on 18)

A method of producing a polypeptide, comprising: cultivating the recombinant host cell of claim 18 under conditions suitable for expression of the polypeptide; and recovering the polypeptide.
